Masimo Corp
NASDAQ:MASI
Masimo Corp
Revenue
Masimo Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Masimo Corp
NASDAQ:MASI
|
Revenue
$2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
14%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Masimo Corp
Revenue Breakdown
Breakdown by Geography
Masimo Corp
Total Revenue:
2B
USD
|
United States:
1.1B
USD
|
EMEA:
571.9m
USD
|
Asia Pacific:
351m
USD
|
Americas:
66.4m
USD
|
Breakdown by Segments
Masimo Corp
See Also
What is Masimo Corp's Revenue?
Revenue
2B
USD
Based on the financial report for Dec 30, 2023, Masimo Corp's Revenue amounts to 2B USD.
What is Masimo Corp's Revenue growth rate?
Revenue CAGR 10Y
14%
Over the last year, the Revenue growth was 1%. The average annual Revenue growth rates for Masimo Corp have been 21% over the past three years , 19% over the past five years , and 14% over the past ten years .